Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Schellong

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
Journal of Thrombosis and Thrombolysis|August 28, 2020
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE studyWalter Ageno, Ivan B Casella, Kok Han Chee, et al.
Circulation|December 18, 2013
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysisSam Schulman, Ajay K Kakkar, Samuel Z Goldhaber, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2023
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registryOmri Cohen, Assaf A Barg, Ulrike Nowak-Göttl, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 2, 2020
Demographic and procedural characteristics in the RECording COurses of vasculaR Diseases (RECCORD) registry - the first 1000 patientsNasser Malyar, Jürgen Stausberg, Ralf Langhoff, et al.
Thrombosis and Haemostasis|November 18, 2016
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilateWalter Ageno, Ivan B Casella, Chee Kok Han, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous ThromboembolismJuan J López-Núñez, Ricard Pérez-Andrés, Pierpaolo Di Micco, et al.
BMC Cardiovascular Disorders|June 16, 2022
Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)Lucie Kretzler, Christoph Mues, Carsten Wunderlich, et al.
The American Journal of Medicine|April 24, 2020
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ StudySamuel Z Goldhaber, Walter Ageno, Ivan B Casella, et al.
Therapeutic Advances in Endocrinology and Metabolism|January 22, 2025
Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding studyChristoph Schindler, Jacek Mikosiński, Pawel Mikosiński, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
Journal of Thrombosis and Thrombolysis|August 28, 2020
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE studyWalter Ageno, Ivan B Casella, Kok Han Chee, et al.
Circulation|December 18, 2013
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysisSam Schulman, Ajay K Kakkar, Samuel Z Goldhaber, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2023
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registryOmri Cohen, Assaf A Barg, Ulrike Nowak-Göttl, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 2, 2020
Demographic and procedural characteristics in the RECording COurses of vasculaR Diseases (RECCORD) registry - the first 1000 patientsNasser Malyar, Jürgen Stausberg, Ralf Langhoff, et al.
Thrombosis and Haemostasis|November 18, 2016
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilateWalter Ageno, Ivan B Casella, Chee Kok Han, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous ThromboembolismJuan J López-Núñez, Ricard Pérez-Andrés, Pierpaolo Di Micco, et al.
BMC Cardiovascular Disorders|June 16, 2022
Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)Lucie Kretzler, Christoph Mues, Carsten Wunderlich, et al.
The American Journal of Medicine|April 24, 2020
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ StudySamuel Z Goldhaber, Walter Ageno, Ivan B Casella, et al.
Therapeutic Advances in Endocrinology and Metabolism|January 22, 2025
Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding studyChristoph Schindler, Jacek Mikosiński, Pawel Mikosiński, et al.
Pageof 12